Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation.
Jens Tomas Van PraetAndreas HuysmanEline De KnijfDe Buyser StefanieSylvia SnauwaertJan Van DroogenbroeckTom LodewyckAlexander F A D SchauwvliegheDominik SelleslagMarijke ReyndersPublished in: The Journal of infectious diseases (2024)
Adverse outcomes of viral respiratory tract infections (RTI) have been reported in recipients of allogeneic hematopoietic cell transplantation. Using a laboratory-developed multiparameter PCR in a consecutive series of 242 patients, we found the highest incidence of viral RTI in the pre-engraftment phase. The occurrence of multiple episodes of viral RTI or viral pneumonia was significantly associated with a higher hazard of non-relapse mortality in the first year after transplantation. We observed a 90-day mortality of 19.7% after viral RTI, which was significantly different between patient groups stratified according to the ISI score.
Keyphrases
- respiratory tract
- sars cov
- stem cell transplantation
- risk factors
- bone marrow
- end stage renal disease
- cardiovascular events
- risk assessment
- ejection fraction
- type diabetes
- newly diagnosed
- cardiovascular disease
- stem cells
- mesenchymal stem cells
- intensive care unit
- case report
- free survival
- extracorporeal membrane oxygenation